JG
IMVT icon

Jain Global’s Immunovant IMVT Stock Holding History

Jain Global’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$992K Buy
+25,754
New +$785K ﹤0.01% 981
2025
Q3 		– Sell
-26,636
Closed -$426K – 1251
2025
Q2 		$426K Buy
+26,636
New +$403K ﹤0.01% 822
2025
Q1 		– Sell
-10,111
Closed -$250K – 1196
2024
Q4 		$250K Buy
+10,111
New +$287K 0.01% 591

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jain Global's IMVT Position: Q2 2026 in Review

Jain Global opened a new position in Immunovant (IMVT) in Q2 2026: 25,754 shares worth $992K. The stake represents ﹤0.01% of the portfolio and ranks #981 among its holdings. This is a return to the name: Jain Global previously reported a position in IMVT as recently as Q2 2025.

Jain Global first reported a position in IMVT in Q4 2024 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Jain Global held 25,754 shares of Immunovant worth $992K as of Q2 2026.
  • Immunovant was a new Jain Global position in Q2 2026.
  • Immunovant made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #981 holding.
  • Jain Global first reported a position in Immunovant in Q4 2024 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.